All In Biotech

Free tool

FAERS Monitor: Dexedrine Spansule

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017078 or its brand name (Dexedrine Spansule, Dextroamphetamine Sulfate). Reports on generic versions are filed under their own applications.

Reports

3,824

Serious

2,051

54% of reports

Hospitalization

567

Death reported

99

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective651
  • fatigue294
  • nausea258
  • anxiety257
  • headache231
  • depression220
  • insomnia193
  • feeling abnormal189
  • somnolence188
  • weight decreased155
  • pain154
  • dizziness141
  • off label use139
  • condition aggravated124
  • diarrhoea113

Reports by year received

View as table
YearReports
200487
200598
200672
2007148
200865
200966
201060
201140
201257
201355
201456
2015258
2016654
2017262
2018290
2019236
2020270
2021147
2022193
2023217
2024213
2025173
2026107

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,335 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
depressionSignal2205.34.7776
somnolenceSignal1885.14.5628
anxietySignal2575.04.4822
feeling abnormalSignal1894.33.8488
insomniaSignal1934.03.5434
weight decreasedSignal1553.12.6215
drug ineffectiveSignal6512.72.5752
condition aggravatedSignal1242.21.985
fatigueSignal2942.11.9169
headacheSignal2312.01.8123
nausea2581.81.693
dizziness1411.61.328
pain1541.41.216
diarrhoea1131.00.80
off label use1390.90.73

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.